Vor Biopharma Inc. (VOR)
Market: NASD |
Currency: USD
Address: 100 Cambridgepark Drive
Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. Its lead product is tremtelectogene empogeditemcel (trem-cel), an engineered hematopoietic stem cell (eHSC) product candidate that is in phase 1/2 trial to treat acute myeloid leukemia (AML) and other hematological malignancies. The company is also developing Mylotarg, a CD33-directed antibody drug conjugate (ADC) therapy for patients with leukemia; VCAR33, a CAR-T therapy designed to target CD33, a clinically validated target for AML, which are under preclinical and Phase 1/2 clinical studies; trem-cel + VCAR33 treatment system that is under preclinical studies for the treatment of AML; and CD33-CLL1 treatment system made with CD33-CLL1 multiplex-engineered eHSC and CD33-CLL1 multi-specific CAR-T, which are under preclinical studies for the treatment of AML. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Show more
📈 Vor Biopharma Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$6.39
-
Upside/Downside from Analyst Target:
2,885.98%
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
10-25%
-
Net Income Growth Range (1Y):
0-10%
-
Revenue Growth Range (1Y):
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Vor Biopharma Inc.
| Date | Reported EPS |
|---|
| 2026-03-18 (estimated upcoming) | - |
| 2025-11-05 (estimated upcoming) | - |
| 2025-11-04 (estimated upcoming) | - |
| 2025-08-06 (estimated upcoming) | - |
| 2025-08-05 (estimated upcoming) | - |
| 2025-05-08 | - |
| 2025-05-06 | - |
| 2025-03-20 | -0.44 |
| 2025-03-17 | - |
| 2024-11-07 | -0.4 |
| 2024-08-08 | -0.41 |
| 2024-08-07 | -0.41 |
| 2024-05-09 | -0.45 |
| 2024-05-08 | -0.45 |
| 2024-03-20 | -0.39 |
| 2024-03-19 | -0.39 |
| 2023-11-07 | -0.49 |
| 2023-11-06 | -0.49 |
| 2023-08-10 | -0.45 |
| 2023-08-09 | -0.45 |
| 2023-05-11 | -0.43 |
| 2023-05-10 | -0.43 |
| 2023-03-23 | -0.52 |
| 2023-03-22 | -0.52 |
| 2022-11-10 | -0.63 |
| 2022-11-09 | -0.63 |
| 2022-08-11 | -0.58 |
| 2022-08-10 | -0.58 |
| 2022-05-12 | -0.61 |
| 2022-05-11 | -0.61 |
| 2022-03-14 | -0.48 |
| 2022-03-13 | -0.48 |
| 2021-11-10 | -0.5 |
| 2021-11-09 | -0.5 |
| 2021-08-09 | -0.5 |
| 2021-08-08 | -0.5 |
| 2021-05-06 | -0.67 |
| 2021-05-05 | -0.67 |
| 2021-03-25 | -217.49 |
| 2021-03-24 | -217.49 |
| 2020-12-18 | - |
| 2020-12-17 | - |
📰 Related News & Research
No related articles found for "vor biopharma".
